Single cell sequencing identifies clonally expanded synovial CD4+ TPH cells expressing GPR56 in rheumatoid arthritis

Alexandra Argyriou(Karolinska University Hospital), Marc H. Wadsworth(Pfizer (United States)), Adrian Lendvai(Karolinska University Hospital), Stephen M. Christensen(Pfizer (United States)), Aase Hensvold(Karolinska University Hospital), Christina Gerstner(Karolinska University Hospital), Annika van Vollenhoven(Karolinska University Hospital), Kellie M. Kravarik(Pfizer (United States)), Aaron Winkler(Pfizer (United States)), Vivianne Malmström(Karolinska University Hospital), Karine Chemin(Karolinska University Hospital)
Nature Communications
July 13, 2022
Cited by 126Open Access
Full Text

Abstract

Abstract Rheumatoid arthritis (RA) is an autoimmune disease affecting synovial joints where different CD4 + T cell subsets may contribute to pathology. Here, we perform single cell sequencing on synovial CD4 + T cells from anti-citrullinated protein antibodies (ACPA)+ and ACPA- RA patients and identify two peripheral helper T cell (T PH ) states and a cytotoxic CD4 + T cell subset. We show that the adhesion G-protein coupled receptor 56 (GPR56) delineates synovial CXCL13 high T PH CD4 + T cells expressing LAG-3 and the tissue-resident memory receptors CXCR6 and CD69. In ACPA- SF, T PH cells display lower levels of GPR56 and LAG-3. Further, most expanded T cell clones in the joint are within CXCL13 high T PH CD4 + T cells. Finally, RNA-velocity analyses suggest a common differentiation pathway between the two T PH clusters and effector CD4 + T cells. Our study provides comprehensive immunoprofiling of the synovial CD4 + T cell subsets in ACPA+ and ACPA- RA.


Related Papers

No related papers found

Powered by citation graph analysis